- Home
- DDL vs VSTM Comparison
DDL vs VSTM Comparison
Compare DDL & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDL | VSTM |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.3M | 723.8M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | DDL | VSTM |
|---|---|---|
| Price | $2.88 | $6.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $13.38 |
| AVG Volume (30 Days) | ★ 2.0M | 1.9M |
| Earning Date | 03-05-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.79 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $3,374,301,331.00 | $13,379,000.00 |
| Revenue This Year | $7.06 | $208.54 |
| Revenue Next Year | $10.31 | $251.40 |
| P/E Ratio | $16.02 | ★ N/A |
| Revenue Growth | 8.43 | ★ 33.79 |
| 52 Week Low | $1.65 | $4.01 |
| 52 Week High | $3.85 | $11.25 |
Technical Indicators
Market Signals| Indicator | DDL | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 58.49 | 36.48 |
| Support Level | $2.55 | $6.31 |
| Resistance Level | $3.11 | $6.78 |
| Average True Range (ATR) | 0.18 | 0.61 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 58.04 | 8.17 |
Price Performance
Historical ComparisonAbout DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.